FDA Grants 510(k) Clearance for AI Detection and Triage of Cervical Spine Fractures
The CINA-CSpine AI software reportedly demonstrated a 90.3 percent sensitivity rate for cervical spine fractures in validation testing on more than 300 non-contrast CT scans.
The CINA-CSpine artificial intelligence (AI) software has garnered 510(k) clearance from the Food and Drug Administration (FDA) for the detection and triage of cervical spine fractures on computed tomography (CT) scans.
Facilitating timely treatment of cervical spine fractures, the CINA-CSpine software provides automated flagging of suspected acute fractures and subsequent alerts to reviewing radiologists, according to Avicenna.AI, the developer of the software.
In validation testing involving over 300 CT scans acquired from 36 scanner models and five different vendors, the company said the newly FDA-cleared CINA-CSpine software demonstrated a 90.3 percent sensitivity for cervical spine fractures. (Photo courtesy of Avicenna.AI .)
In validation testing involving over 300 CT scans acquired from 36 scanner models and five different vendors, the company said the CINA-CSpine software demonstrated a 90.3 percent sensitivity rate and a 91.9 percent specificity rate for cervical spine fractures.
"These results demonstrate that our CINA-CSpine algorithm is capable of providing prompt and accurate findings that could positively guide physicians towards better assessments and improved patient outcomes," added Cyril Di Grandi, the co-founder and chief executive officer of Avicenna.ai.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
